APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aminoglycosides Antibiotics Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Aminoglycosides Antibiotics Drug Industry Growth and Trends Forecast to 2032

2 January 2026103 pages

Choose your research edition.

Industry ResearchAminoglycosides Antibiotics Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Aminoglycosides Antibiotics Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Aminoglycosides Antibiotics Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aminoglycosides Antibiotics Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Aminoglycosides Antibiotics Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

According to APO Research, the global Aminoglycosides Antibiotics Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Aminoglycosides Antibiotics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Aminoglycosides Antibiotics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aminoglycosides Antibiotics Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Aminoglycosides Antibiotics Drug market include Teva, Novartis, Pfizer, Fresenius Kabi, Sun Pharma, Lannett Company, Jemicare, Hikma and Fangyuan-pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Aminoglycosides Antibiotics Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Aminoglycosides Antibiotics Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aminoglycosides Antibiotics Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aminoglycosides Antibiotics Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Aminoglycosides Antibiotics Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Aminoglycosides Antibiotics Drug Market by Company

Teva

Novartis

Pfizer

Fresenius Kabi

Sun Pharma

Lannett Company

Jemicare

Hikma

Fangyuan-pharma

Cipla

Aike Pharmaceutical

Aminoglycosides Antibiotics Drug Segment by Type

Etimicin

Neomycin

Tobramycin

Gentamicin

Amikacin

Others

Aminoglycosides Antibiotics Drug Segment by Application

Hospital

Clinic

Others

Aminoglycosides Antibiotics Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aminoglycosides Antibiotics Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aminoglycosides Antibiotics Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aminoglycosides Antibiotics Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Aminoglycosides Antibiotics Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Aminoglycosides Antibiotics Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Aminoglycosides Antibiotics Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Aminoglycosides Antibiotics Drug Market Share by Region (2021-2026) Table 4. Global Aminoglycosides Antibiotics Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Aminoglycosides Antibiotics Drug Market Share by Region (2027-2032) Table 6. Global Aminoglycosides Antibiotics Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Aminoglycosides Antibiotics Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Aminoglycosides Antibiotics Drug Market Size Share by Type (2021-2026) Table 9. Global Aminoglycosides Antibiotics Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Aminoglycosides Antibiotics Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Aminoglycosides Antibiotics Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Aminoglycosides Antibiotics Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Aminoglycosides Antibiotics Drug Market Size Share by Application (2021-2026) Table 24. Global Aminoglycosides Antibiotics Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Aminoglycosides Antibiotics Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Aminoglycosides Antibiotics Drug Industry Trends Table 37. Aminoglycosides Antibiotics Drug Industry Drivers Table 38. Aminoglycosides Antibiotics Drug Industry Opportunities and Challenges Table 39. Aminoglycosides Antibiotics Drug Industry Restraints Table 40. Global Aminoglycosides Antibiotics Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Aminoglycosides Antibiotics Drug Revenue Market Share by Company (2021-2026) Table 42. Global Aminoglycosides Antibiotics Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Aminoglycosides Antibiotics Drug Key Company Headquarters & Area Served Table 44. Global Aminoglycosides Antibiotics Drug Company, Product Type & Application Table 45. Global Aminoglycosides Antibiotics Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Aminoglycosides Antibiotics Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Company Information Table 49. Teva Business Overview Table 50. Teva Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Aminoglycosides Antibiotics Drug Product Portfolio Table 52. Teva Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis Aminoglycosides Antibiotics Drug Product Portfolio Table 57. Novartis Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Pfizer Aminoglycosides Antibiotics Drug Product Portfolio Table 62. Pfizer Recent Development Table 63. Fresenius Kabi Company Information Table 64. Fresenius Kabi Business Overview Table 65. Fresenius Kabi Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Fresenius Kabi Aminoglycosides Antibiotics Drug Product Portfolio Table 67. Fresenius Kabi Recent Development Table 68. Sun Pharma Company Information Table 69. Sun Pharma Business Overview Table 70. Sun Pharma Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sun Pharma Aminoglycosides Antibiotics Drug Product Portfolio Table 72. Sun Pharma Recent Development Table 73. Lannett Company Company Information Table 74. Lannett Company Business Overview Table 75. Lannett Company Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Lannett Company Aminoglycosides Antibiotics Drug Product Portfolio Table 77. Lannett Company Recent Development Table 78. Jemicare Company Information Table 79. Jemicare Business Overview Table 80. Jemicare Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Jemicare Aminoglycosides Antibiotics Drug Product Portfolio Table 82. Jemicare Recent Development Table 83. Hikma Company Information Table 84. Hikma Business Overview Table 85. Hikma Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Hikma Aminoglycosides Antibiotics Drug Product Portfolio Table 87. Hikma Recent Development Table 88. Fangyuan-pharma Company Information Table 89. Fangyuan-pharma Business Overview Table 90. Fangyuan-pharma Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Fangyuan-pharma Aminoglycosides Antibiotics Drug Product Portfolio Table 92. Fangyuan-pharma Recent Development Table 93. Cipla Company Information Table 94. Cipla Business Overview Table 95. Cipla Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Cipla Aminoglycosides Antibiotics Drug Product Portfolio Table 97. Cipla Recent Development Table 98. Aike Pharmaceutical Company Information Table 99. Aike Pharmaceutical Business Overview Table 100. Aike Pharmaceutical Aminoglycosides Antibiotics Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Aike Pharmaceutical Aminoglycosides Antibiotics Drug Product Portfolio Table 102. Aike Pharmaceutical Recent Development Table 103. North America Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Aminoglycosides Antibiotics Drug Market Share by Country (2021-2026) Table 106. North America Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Aminoglycosides Antibiotics Drug Market Share Forecast by Country (2027-2032) Table 108. Europe Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Aminoglycosides Antibiotics Drug Market Share by Country (2021-2026) Table 111. Europe Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Aminoglycosides Antibiotics Drug Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Aminoglycosides Antibiotics Drug Market Share by Country (2021-2026) Table 116. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Aminoglycosides Antibiotics Drug Market Share Forecast by Country (2027-2032) Table 118. Latin America Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Aminoglycosides Antibiotics Drug Market Share by Country (2021-2026) Table 121. Latin America Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Aminoglycosides Antibiotics Drug Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Country (2021-2026) Table 126. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Aminoglycosides Antibiotics Drug Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Aminoglycosides Antibiotics Drug Product Image Figure 3. Global Aminoglycosides Antibiotics Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Aminoglycosides Antibiotics Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Aminoglycosides Antibiotics Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Aminoglycosides Antibiotics Drug Market Share by Region (2021-2032) Figure 7. North America Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Etimicin Image Figure 13. Global Etimicin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Neomycin Image Figure 15. Global Neomycin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Tobramycin Image Figure 17. Global Tobramycin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Gentamicin Image Figure 19. Global Gentamicin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Amikacin Image Figure 21. Global Amikacin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Aminoglycosides Antibiotics Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Aminoglycosides Antibiotics Drug Market Share by Type 2025 VS 2032 Figure 26. North America Aminoglycosides Antibiotics Drug Market Size Share by Type (2021-2032) Figure 27. Europe Aminoglycosides Antibiotics Drug Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Share by Type (2021-2032) Figure 29. Latin America Aminoglycosides Antibiotics Drug Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Aminoglycosides Antibiotics Drug Market Size Share by Type (2021-2032) Figure 31. Hospital Image Figure 32. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Clinic Image Figure 34. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Aminoglycosides Antibiotics Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Aminoglycosides Antibiotics Drug Market Share by Application 2025 VS 2032 Figure 39. North America Aminoglycosides Antibiotics Drug Market Size Share by Application (2021-2032) Figure 40. Europe Aminoglycosides Antibiotics Drug Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Share by Application (2021-2032) Figure 42. Latin America Aminoglycosides Antibiotics Drug Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Aminoglycosides Antibiotics Drug Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Aminoglycosides Antibiotics Drug Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Aminoglycosides Antibiotics Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Aminoglycosides Antibiotics Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 49. Europe Aminoglycosides Antibiotics Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Aminoglycosides Antibiotics Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 52. Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Aminoglycosides Antibiotics Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 55. Latin America Aminoglycosides Antibiotics Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Aminoglycosides Antibiotics Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 58. Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Aminoglycosides Antibiotics Drug Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Etimicin
  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Novartis
  • Pfizer
  • Fresenius Kabi
  • Sun Pharma
  • Lannett Company
  • Jemicare
  • Hikma
  • Fangyuan-pharma
  • Cipla
  • Aike Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Aminoglycosides Antibiotics Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Aminoglycosides Antibiotics Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Aminoglycosides Antibiotics Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Aminoglycosides Antibiotics Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Aminoglycosides Antibiotics Drug Market Size (2021-2032)
  8. 1.5.1 North America Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Growth Rate (2021-2032)
2 Aminoglycosides Antibiotics Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Etimicin
  3. 2.1.2 Neomycin
  4. 2.1.3 Tobramycin
  5. 2.1.4 Gentamicin
  6. 2.1.5 Amikacin
  7. 2.1.6 Others
  8. 2.2 Global Aminoglycosides Antibiotics Drug Market Size by Type
  9. 2.2.1 Global Aminoglycosides Antibiotics Drug Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Aminoglycosides Antibiotics Drug Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Aminoglycosides Antibiotics Drug Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Aminoglycosides Antibiotics Drug Market Size by Regions
  13. 2.3.1 North America Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Aminoglycosides Antibiotics Drug Market Size Breakdown by Type (2021-2026)
3 Aminoglycosides Antibiotics Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Aminoglycosides Antibiotics Drug Market Size by Application
  6. 3.2.1 Global Aminoglycosides Antibiotics Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Aminoglycosides Antibiotics Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Aminoglycosides Antibiotics Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Aminoglycosides Antibiotics Drug Market Size by Regions
  10. 3.3.1 North America Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Aminoglycosides Antibiotics Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Aminoglycosides Antibiotics Drug Industry Trends
  2. 4.2 Aminoglycosides Antibiotics Drug Industry Drivers
  3. 4.3 Aminoglycosides Antibiotics Drug Industry Opportunities and Challenges
  4. 4.4 Aminoglycosides Antibiotics Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Aminoglycosides Antibiotics Drug Revenue (2021-2026)
  2. 5.2 Global Aminoglycosides Antibiotics Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Aminoglycosides Antibiotics Drug Key Company Headquarters & Area Served
  4. 5.4 Global Aminoglycosides Antibiotics Drug Company, Product Type & Application
  5. 5.5 Global Aminoglycosides Antibiotics Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Aminoglycosides Antibiotics Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Aminoglycosides Antibiotics Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Aminoglycosides Antibiotics Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Aminoglycosides Antibiotics Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Aminoglycosides Antibiotics Drug Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Aminoglycosides Antibiotics Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Aminoglycosides Antibiotics Drug Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Sun Pharma
  26. 6.5.1 Sun Pharma Company Information
  27. 6.5.2 Sun Pharma Business Overview
  28. 6.5.3 Sun Pharma Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sun Pharma Aminoglycosides Antibiotics Drug Product Portfolio
  30. 6.5.5 Sun Pharma Recent Developments
  31. 6.6 Lannett Company
  32. 6.6.1 Lannett Company Company Information
  33. 6.6.2 Lannett Company Business Overview
  34. 6.6.3 Lannett Company Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Lannett Company Aminoglycosides Antibiotics Drug Product Portfolio
  36. 6.6.5 Lannett Company Recent Developments
  37. 6.7 Jemicare
  38. 6.7.1 Jemicare Company Information
  39. 6.7.2 Jemicare Business Overview
  40. 6.7.3 Jemicare Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Jemicare Aminoglycosides Antibiotics Drug Product Portfolio
  42. 6.7.5 Jemicare Recent Developments
  43. 6.8 Hikma
  44. 6.8.1 Hikma Company Information
  45. 6.8.2 Hikma Business Overview
  46. 6.8.3 Hikma Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Hikma Aminoglycosides Antibiotics Drug Product Portfolio
  48. 6.8.5 Hikma Recent Developments
  49. 6.9 Fangyuan-pharma
  50. 6.9.1 Fangyuan-pharma Company Information
  51. 6.9.2 Fangyuan-pharma Business Overview
  52. 6.9.3 Fangyuan-pharma Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Fangyuan-pharma Aminoglycosides Antibiotics Drug Product Portfolio
  54. 6.9.5 Fangyuan-pharma Recent Developments
  55. 6.10 Cipla
  56. 6.10.1 Cipla Company Information
  57. 6.10.2 Cipla Business Overview
  58. 6.10.3 Cipla Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Cipla Aminoglycosides Antibiotics Drug Product Portfolio
  60. 6.10.5 Cipla Recent Developments
  61. 6.11 Aike Pharmaceutical
  62. 6.11.1 Aike Pharmaceutical Company Information
  63. 6.11.2 Aike Pharmaceutical Business Overview
  64. 6.11.3 Aike Pharmaceutical Aminoglycosides Antibiotics Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Aike Pharmaceutical Aminoglycosides Antibiotics Drug Product Portfolio
  66. 6.11.5 Aike Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  3. 7.3 North America Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  3. 10.3 South America Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Aminoglycosides Antibiotics Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst